RMTI

Rockwell Medical, Inc. is a biopharmaceutical innovator dedicated to improving the lives of patients suffering from end-stage renal disease and chronic kidney disease. Headquartered in Wixom, Michigan, the company specializes in proprietary treatments for iron deficiency and advanced hemodialysis solutions. With a robust portfolio aimed at enhancing patient outcomes, Rockwell is strategically positioned in a growing market characterized by an increasing demand for specialized renal therapies. Its commitment to addressing critical patient needs reinforces its status as a pivotal player in the biopharmaceutical sector.